Skip to Main Content

WASHINGTON — The next year at the Food and Drug Administration is going to make Robert Califf’s marathon confirmation process look easy.

The longtime Duke cardiologist, who was narrowly confirmed by the Senate Tuesday, inherits an agency that is smack dab in the middle of deliberations over a slew of controversial applications for everything from pediatric Covid-19 vaccines to ALS drugs.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


Create a display name to comment

This name will appear with your comment